NCT04351347招募中2 期
Clinical Study Evaluating the Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Number of patients with improvement or died
研究概览
简要总结
Efficacy of Ivermectin in larger doses in COVID-19 treatment
详细描述
Clinical Study Evaluating the Efficacy of Ivermectin in higher doses in COVID-19 treatment
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with covid 19
排除标准
- •Allergy or side effects to treatment
研究组 & 干预措施
Ivermectin
Experimental
Ivermectin alone in larger doses
干预措施: Ivermectin (Drug)
结局指标
主要结局
Number of patients with improvement or died
时间窗: 1 month
The number of patients with improvement or death
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Tanta University
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Ivermectin as a Novel Therapy in COVID-19 TreatmentCOVIDNCT04403555Tanta University164
已完成
3 期
Ivermectin Treatment Efficacy in Covid-19 High Risk PatientsCOVID-19NCT04920942Clinical Research Centre, Malaysia500
Unknown
不适用
Efficacy of Ivermectin in COVID-19COVIDNCT04392713Combined Military Hospital, Pakistan100
已完成
2 期
Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)Covid19NCT04894721Ministry of Public Health, Argentina172
Unknown
2 期
The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)Covid19NCT04712279Corpometria Institute294